Atomwise
AI superplatform that explores chemical space to discover novel, drug-like molecules
Enterprise·Technical·Powered by Proprietary ML (AtomNet)
Key strengths
AI/ML-powered drug discoveryExploration of vast chemical space for novel drug-like moleculesFocus on immune and inflammatory diseasesSmall-molecule drug discovery
Enterprise pricing
San Francisco, USA
Founded 2012
Facts verified against atomwise.com on
Get alerts when Atomwise changes
Free. We'll email you when pricing, the free tier, API access or open-source status changes.
No ratings yet
Atomwise is well suited for technical teams tackling the following challenges in drug discovery pipelines:
- Chemical space exploration: Using ML to search across vast libraries of potential small molecules to surface novel, drug-like candidates.
- Hit identification: Accelerating early-stage discovery by applying AI models to identify viable starting points for drug programs.
- Immune and inflammatory disease targets: Focused application of ML-driven discovery to molecular targets relevant to immune and inflammatory conditions.
- Small-molecule drug discovery: End-to-end support for small-molecule programs within pharmaceutical and biotech R&D workflows.
Alternatives
See all alternatives